Dorsey Brian's Form 4 filing
ARS Pharmaceuticals, Inc. (SPRY) · filed Dec 13, 2024
- Accession no.
- 0001415889-24-029376
- Filed
- Dec 13, 2024
- Trade date
- Dec 11-12, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $493.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dorsey BrianCIK 0001380762 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | Common Stock | MOption exerciseAcquired | +15,000 | $0.64 | +$9,600 | 21,024 | Direct | |
| Dec 11, 2024 | Common Stock | SSaleDisposed | −15,000 | $12.43 | −$186,450 | 6,024 | Direct | |
| Dec 12, 2024 | Common Stock | MOption exerciseAcquired | +25,000 | $0.64 | +$16,000 | 31,024 | Direct | |
| Dec 12, 2024 | Common Stock | SSaleDisposed | −25,000 | $12.30 | −$307,500 | 6,024 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 46,828 | Direct | |
| Dec 12, 2024 | Common Stock | MOption exerciseDisposed | −25,000 | $0.00 | $0 | 21,828 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.